|
1
|
Cellular signaling by fibroblast growth factor receptors.
|
2005
|
9.62
|
|
2
|
Interleukin-17 family and IL-17 receptors.
|
2003
|
5.57
|
|
3
|
Structural basis for fibroblast growth factor receptor activation.
|
2005
|
4.69
|
|
4
|
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.
|
2005
|
4.65
|
|
5
|
Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer.
|
2009
|
4.10
|
|
6
|
Alterations in components of the TGF-beta superfamily signaling pathways in human cancer.
|
2005
|
4.05
|
|
7
|
BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk.
|
2005
|
3.97
|
|
8
|
The CC chemokine CCL20 and its receptor CCR6.
|
2003
|
3.96
|
|
9
|
Fibroblast growth factor signaling in tumorigenesis.
|
2005
|
3.91
|
|
10
|
Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts.
|
1997
|
3.86
|
|
11
|
Mechanisms involved in the therapeutic properties of mesenchymal stem cells.
|
2009
|
3.73
|
|
12
|
The balance between IL-1 and IL-1Ra in disease.
|
2002
|
3.69
|
|
13
|
Biology of interleukin-10.
|
2010
|
3.41
|
|
14
|
TGF-beta and cancer.
|
2005
|
3.38
|
|
15
|
The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion.
|
2001
|
3.34
|
|
16
|
The growing family of interferon regulatory factors.
|
1997
|
3.33
|
|
17
|
The PDGF family: four gene products form five dimeric isoforms.
|
2004
|
3.29
|
|
18
|
Mechanisms underlying differential responses to FGF signaling.
|
2005
|
3.28
|
|
19
|
The roles of IFN gamma in protection against tumor development and cancer immunoediting.
|
2002
|
3.28
|
|
20
|
Interleukin-8 and human cancer biology.
|
2001
|
3.27
|
|
21
|
Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology.
|
2000
|
3.18
|
|
22
|
Regulation of PDGF and its receptors in fibrotic diseases.
|
2004
|
3.14
|
|
23
|
Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity.
|
1997
|
3.11
|
|
24
|
Osteopontin: role in immune regulation and stress responses.
|
2008
|
3.06
|
|
25
|
IL-6 in autoimmune disease and chronic inflammatory proliferative disease.
|
2002
|
2.99
|
|
26
|
Cytokine-mediated inflammation in acute lung injury.
|
2003
|
2.95
|
|
27
|
Macrophage inflammatory protein-1.
|
2002
|
2.93
|
|
28
|
Tumor necrosis factor or tumor promoting factor?
|
2002
|
2.89
|
|
29
|
Interleukin-12 in anti-tumor immunity and immunotherapy.
|
2002
|
2.86
|
|
30
|
Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy.
|
2003
|
2.84
|
|
31
|
Interleukin-1.
|
1997
|
2.77
|
|
32
|
Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells.
|
2006
|
2.73
|
|
33
|
IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology.
|
2004
|
2.72
|
|
34
|
Both integrated and differential regulation of components of the IL-2/IL-2 receptor system.
|
2006
|
2.71
|
|
35
|
Regulation of cytokine signaling and inflammation.
|
2002
|
2.69
|
|
36
|
Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis.
|
2005
|
2.69
|
|
37
|
The signaling adaptors and pathways activated by TNF superfamily.
|
2003
|
2.66
|
|
38
|
PDGF and cardiovascular disease.
|
2004
|
2.64
|
|
39
|
The biology of IL-12: coordinating innate and adaptive immune responses.
|
2003
|
2.62
|
|
40
|
Recent advances in BMP receptor signaling.
|
2009
|
2.57
|
|
41
|
Tumor suppressor activity of the TGF-beta pathway in human cancers.
|
1996
|
2.57
|
|
42
|
Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses.
|
2006
|
2.57
|
|
43
|
PDGF signaling in cells and mice.
|
2004
|
2.57
|
|
44
|
Signal transduction by bone morphogenetic proteins.
|
1998
|
2.56
|
|
45
|
Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu.
|
2001
|
2.52
|
|
46
|
Chemokines in cancer.
|
2002
|
2.47
|
|
47
|
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.
|
2011
|
2.42
|
|
48
|
Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis.
|
2008
|
2.40
|
|
49
|
Insight into the physiological functions of PDGF through genetic studies in mice.
|
2004
|
2.39
|
|
50
|
Cell biology of IL-7, a key lymphotrophin.
|
2005
|
2.35
|